Dementia News and Research

Latest Dementia News and Research

Physical activity may moderate impact of stress on telomeres

UCSF scientists are reporting several studies showing that psychological stress leads to shorter telomeres - the protective caps on the ends of chromosomes that are a measure of cell age and, thus, health. The findings also suggest that exercise may prevent this damage.

5 Apr 2011

Researchers to develop future body sensor network

Modern man is surrounded by a multitude of sensors. Today's sensors are simple and made for specific purposes, like measuring temperature, balance, build-up of smoke, or tyre pressure. The common trait of the sensors is that they are all embedded in a closed system.

5 Apr 2011

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.

5 Apr 2011

New insight into Parkinson's disease

As Parkinson's Awareness Month gets underway, a Canadian-led international study is providing important new insight into Parkinson's disease and paving the way for new avenues for clinical trials.

5 Apr 2011

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.

5 Apr 2011

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.

4 Apr 2011

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.

4 Apr 2011

Scientists identify five new genes that increase risk of developing Alzheimer's

A leading UK scientist's search for factors that increase the risk of developing Alzheimer's has uncovered five new genes to help pinpoint what's going wrong in the brain.

4 Apr 2011

Researchers identify four new genes linked to Alzheimer's disease

In the largest study of its kind, researchers from a consortium of 44 universities and research institutions in the United States, including Rush University Medical Center, identified four new genes linked to Alzheimer's disease. Each gene individually adds to the risk of having this common form of dementia later in life.

4 Apr 2011

Discovery of 4 new genes associated with Alzheimer's

In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, Boston University School of Medicine and the University of Miami identified four new genes linked to Alzheimer's disease. Each gene individually adds to the risk of having this common form of dementia later in life. These new genes offer a portal into what causes Alzheimer's disease and is a major advance in the field.

3 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta - the primary constituent of the plaques found in the brains of Alzheimer's disease patients - also had changes in brain structure similar to those seen in Alzheimer's patients.

31 Mar 2011

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Dr. Sube Banerjee, one of the world's leading experts on Alzheimer's disease is the recipient of an international award for the best evidence-based psychosocial intervention for people with dementia and their caregivers.

30 Mar 2011

New research to examine links between aluminium and Alzheimer's disease

New research is being carried out at Keele university to examine links between aluminium and Alzheimer's disease.

29 Mar 2011

Atypical antipsychotics is a safe mental health medication for nursing home residents

Conventional antipsychotics, antidepressants and benzodiazepines often administered to nursing home residents are no safer than atypical antipsychotics and may carry increased risks, according to an article in CMAJ.

29 Mar 2011

Dementia & Alzheimer’s drug trial with sleep hormone melatonin

A new drug is in the making that could improve the quality of life for people with dementia. Glasgow-based medical research company CPS Research is conducting a clinical trial using a drug containing the sleep hormone melatonin, which it is hoped will reduce the symptoms associated with the illness.

28 Mar 2011

Geriatrician provides latest Alzheimer drug research developments at International conference

Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.

28 Mar 2011

Experts to address worldwide impact of Alzheimer's disease at ADI conference

On Sunday March 27 leaders at the 26th Annual Conference of Alzheimer's Disease International will challenge the World Health Organization and countries around the world to take action on the dramatic surge in the global incidence of Alzheimer's disease and dementia.

25 Mar 2011

Elder abuse victims more likely to suffer from mental disorder, use drugs or alcohol

Victims of severe traumatic elder abuse are more likely to be female, suffer from a neurological or mental disorder, and to abuse drugs or alcohol, according to research published in the March issue of the Journal of the American Geriatrics Society.

23 Mar 2011

Asuragen introduces CE-mark approved AmplideX FMR1 PCR Kit

Asuragen, Inc. announced that they have achieved CE-marking and commercial launch in Europe of the AmplideX FMR1 PCR Kit for the detection of CGG repeats in the fragile X mental retardation gene.

23 Mar 2011

Dementia News and Research

Latest Dementia News and Research

Physical activity may moderate impact of stress on telomeres

Researchers to develop future body sensor network

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New insight into Parkinson's disease

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Scientists identify five new genes that increase risk of developing Alzheimer's

Researchers identify four new genes linked to Alzheimer's disease

Discovery of 4 new genes associated with Alzheimer's

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

New research to examine links between aluminium and Alzheimer's disease

Atypical antipsychotics is a safe mental health medication for nursing home residents

Dementia & Alzheimer’s drug trial with sleep hormone melatonin

Geriatrician provides latest Alzheimer drug research developments at International conference

Experts to address worldwide impact of Alzheimer's disease at ADI conference

Elder abuse victims more likely to suffer from mental disorder, use drugs or alcohol

Asuragen introduces CE-mark approved AmplideX FMR1 PCR Kit

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Dementia News and Research

Latest Dementia News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in